annual net income:
-$320.63M+$55.70M(+14.80%)Summary
- As of today (September 16, 2025), TVTX annual net profit is -$320.63 million, with the most recent change of +$55.70 million (+14.80%) on December 31, 2024.
- During the last 3 years, TVTX annual net income has fallen by -$140.54 million (-78.04%).
- TVTX annual net income is now -373.49% below its all-time high of $117.24 million, reached on December 31, 2015.
Performance
TVTX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$12.76M+$28.47M(+69.06%)Summary
- As of today (September 16, 2025), TVTX quarterly net profit is -$12.76 million, with the most recent change of +$28.47 million (+69.06%) on June 30, 2025.
- Over the past year, TVTX quarterly net income has increased by +$56.90 million (+81.69%).
- TVTX quarterly net income is now -112.08% below its all-time high of $105.58 million, reached on September 30, 2015.
Performance
TVTX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$169.00M+$56.90M(+25.19%)Summary
- As of today (September 16, 2025), TVTX TTM net profit is -$169.00 million, with the most recent change of +$56.90 million (+25.19%) on June 30, 2025.
- Over the past year, TVTX TTM net income has increased by +$214.45 million (+55.93%).
- TVTX TTM net income is now -244.15% below its all-time high of $117.24 million, reached on December 31, 2015.
Performance
TVTX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TVTX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.8% | +81.7% | +55.9% |
| 3 y3 years | -78.0% | +81.0% | +26.6% |
| 5 y5 years | -119.0% | +51.1% | -83.7% |
TVTX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -78.0% | +14.8% | at high | +90.6% | at high | +57.7% |
| 5 y | 5-year | -119.0% | +14.8% | at high | +90.6% | -116.5% | +57.7% |
| alltime | all time | -373.5% | +14.8% | -112.1% | +90.6% | -244.2% | +57.7% |
TVTX Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$12.76M(-69.1%) | -$169.00M(-25.2%) |
| Mar 2025 | - | -$41.23M(-31.6%) | -$225.90M(-29.5%) |
| Dec 2024 | -$320.63M(-14.8%) | -$60.27M(+10.1%) | -$320.63M(-8.1%) |
| Sep 2024 | - | -$54.75M(-21.4%) | -$348.96M(-9.0%) |
| Jun 2024 | - | -$69.65M(-48.8%) | -$383.45M(-4.0%) |
| Mar 2024 | - | -$135.96M(+53.5%) | -$399.43M(+10.9%) |
| Dec 2023 | -$376.33M(+13.5%) | -$88.60M(-0.7%) | -$360.03M(+0.8%) |
| Sep 2023 | - | -$89.24M(+4.2%) | -$357.07M(+1.5%) |
| Jun 2023 | - | -$85.63M(-11.3%) | -$351.89M(+5.6%) |
| Mar 2023 | - | -$96.56M(+12.8%) | -$333.30M(+6.6%) |
| Dec 2022 | -$331.47M(+84.1%) | -$85.64M(+1.9%) | -$312.70M(+12.2%) |
| Sep 2022 | - | -$84.06M(+25.4%) | -$278.64M(+21.0%) |
| Jun 2022 | - | -$67.03M(-11.8%) | -$230.22M(+13.9%) |
| Mar 2022 | - | -$75.97M(+47.3%) | -$202.19M(+12.3%) |
| Dec 2021 | -$180.09M(+6.3%) | -$51.57M(+44.7%) | -$180.09M(-28.0%) |
| Sep 2021 | - | -$35.64M(-8.6%) | -$250.14M(+5.5%) |
| Jun 2021 | - | -$39.01M(-27.6%) | -$237.05M(+5.8%) |
| Mar 2021 | - | -$53.87M(-55.7%) | -$224.11M(+32.3%) |
| Dec 2020 | -$169.43M(+15.7%) | -$121.62M(+439.4%) | -$169.43M(+117.0%) |
| Sep 2020 | - | -$22.55M(-13.5%) | -$78.07M(-15.2%) |
| Jun 2020 | - | -$26.07M(-3326.2%) | -$92.01M(-12.1%) |
| Mar 2020 | - | $808.00K(-102.7%) | -$104.64M(-28.5%) |
| Dec 2019 | -$146.43M(+42.6%) | -$30.26M(-17.1%) | -$146.43M(+18.4%) |
| Sep 2019 | - | -$36.49M(-5.7%) | -$123.62M(-12.7%) |
| Jun 2019 | - | -$38.70M(-5.6%) | -$141.65M(+13.1%) |
| Mar 2019 | - | -$40.98M(+449.7%) | -$125.28M(+22.0%) |
| Dec 2018 | -$102.68M(+71.9%) | -$7.46M(-86.3%) | -$102.68M(-9.0%) |
| Sep 2018 | - | -$54.52M(+144.1%) | -$112.84M(+48.2%) |
| Jun 2018 | - | -$22.33M(+21.5%) | -$76.12M(+13.6%) |
| Mar 2018 | - | -$18.38M(+4.3%) | -$67.02M(+12.2%) |
| Dec 2017 | -$59.73M | -$17.62M(-1.0%) | -$59.73M(+17.8%) |
| Sep 2017 | - | -$17.79M(+34.5%) | -$50.72M(-27.6%) |
| Jun 2017 | - | -$13.23M(+19.3%) | -$70.03M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$11.09M(+28.9%) | -$70.21M(+46.6%) |
| Dec 2016 | -$47.90M(-140.9%) | -$8.60M(-76.8%) | -$47.90M(+14.7%) |
| Sep 2016 | - | -$37.11M(+176.9%) | -$41.77M(-141.4%) |
| Jun 2016 | - | -$13.40M(-219.5%) | $100.92M(+13.7%) |
| Mar 2016 | - | $11.22M(-554.3%) | $88.80M(-24.3%) |
| Dec 2015 | $117.24M(-205.7%) | -$2.47M(-102.3%) | $117.24M(+29.3%) |
| Sep 2015 | - | $105.58M(-513.6%) | $90.68M(-363.2%) |
| Jun 2015 | - | -$25.53M(-164.4%) | -$34.46M(+7632.4%) |
| Mar 2015 | - | $39.66M(-236.6%) | -$445.60K(-99.6%) |
| Dec 2014 | -$110.94M(+220.4%) | -$29.03M(+48.4%) | -$110.73M(+17.1%) |
| Sep 2014 | - | -$19.56M(-330.5%) | -$94.52M(+10.1%) |
| Jun 2014 | - | $8.48M(-112.0%) | -$85.86M(-13.6%) |
| Mar 2014 | - | -$70.63M(+450.8%) | -$99.39M(+196.6%) |
| Dec 2013 | -$34.62M(+14.1%) | -$12.82M(+17.7%) | -$33.51M(-34.3%) |
| Sep 2013 | - | -$10.90M(+115.9%) | -$51.02M(+27.2%) |
| Jun 2013 | - | -$5.05M(+6.4%) | -$40.12M(+14.4%) |
| Mar 2013 | - | -$4.74M(-84.4%) | -$35.08M(+15.6%) |
| Dec 2012 | -$30.34M(>+9900.0%) | -$30.33M(>+9900.0%) | -$30.33M(>+9900.0%) |
| Nov 2011 | - | -$3500.00(0.0%) | -$14.60K(-13.1%) |
| Aug 2011 | - | -$3500.00(0.0%) | -$16.80K(-15.6%) |
| May 2011 | - | -$3500.00(-14.6%) | -$19.90K(-13.5%) |
| Feb 2011 | -$23.00K(-17.9%) | -$4100.00(-28.1%) | -$23.00K(-11.2%) |
| Nov 2010 | - | -$5700.00(-13.6%) | -$25.90K(-3.4%) |
| Aug 2010 | - | -$6600.00(0.0%) | -$26.80K(-0.4%) |
| May 2010 | - | -$6600.00(-5.7%) | -$26.90K(-3.6%) |
| Feb 2010 | -$28.00K(+53.0%) | -$7000.00(+6.1%) | -$27.90K(-2.1%) |
| Nov 2009 | - | -$6600.00(-1.5%) | -$28.50K(+8.8%) |
| Aug 2009 | - | -$6700.00(-11.8%) | -$26.20K(+15.9%) |
| May 2009 | - | -$7600.00(0.0%) | -$22.60K(+22.8%) |
| Feb 2009 | -$18.30K(-64.8%) | -$7600.00(+76.7%) | -$18.40K(+70.4%) |
| Nov 2008 | - | -$4300.00(+38.7%) | -$10.80K(+66.2%) |
| Aug 2008 | - | -$3100.00(-8.8%) | -$6500.00(+91.2%) |
| May 2008 | - | -$3400.00 | -$3400.00 |
| Feb 2008 | -$52.00K | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual net profit?
- What is the all time high annual net income for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual net income year-on-year change?
- What is Travere Therapeutics, Inc. quarterly net profit?
- What is the all time high quarterly net income for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly net income year-on-year change?
- What is Travere Therapeutics, Inc. TTM net profit?
- What is the all time high TTM net income for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM net income year-on-year change?
What is Travere Therapeutics, Inc. annual net profit?
The current annual net income of TVTX is -$320.63M
What is the all time high annual net income for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual net profit is $117.24M
What is Travere Therapeutics, Inc. annual net income year-on-year change?
Over the past year, TVTX annual net profit has changed by +$55.70M (+14.80%)
What is Travere Therapeutics, Inc. quarterly net profit?
The current quarterly net income of TVTX is -$12.76M
What is the all time high quarterly net income for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly net profit is $105.58M
What is Travere Therapeutics, Inc. quarterly net income year-on-year change?
Over the past year, TVTX quarterly net profit has changed by +$56.90M (+81.69%)
What is Travere Therapeutics, Inc. TTM net profit?
The current TTM net income of TVTX is -$169.00M
What is the all time high TTM net income for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM net profit is $117.24M
What is Travere Therapeutics, Inc. TTM net income year-on-year change?
Over the past year, TVTX TTM net profit has changed by +$214.45M (+55.93%)